In May, AACR's journals editors highlighted studies on CD28’s impact on CAR T-cell activity, the relationship between neurons and...
The latest edition of our "From the Bench" series examines creative research approaches presented at the AACR Annual Meeting...
In April 2026, AACR's journals editors highlighted studies on cancer survivors taking GLP-1 agonists, an immunotherapy-boosting bacteria, and more.
In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
In March, AACR's journals editors highlighted studies on the development of pediatric leukemia, the use of low-dose tamoxifen, and...
In February, the editors of AACR's journals highlighted studies on the FDA’s accelerated approval pathway, how metabolism impacts prostate...
The AACR, The Mark Foundation, Lustgarten Foundation, Break Through Cancer, and Tina’s Wish will explore early detection approaches for...
What does a naked mole rat, a nuclear exporter that “moonlights” as a chromatin regulator, and the combined power...
The countdown to the new year is nearly upon us, but no need to count down to the last...
Frank McCormick, PhD, FAACR, reflected on a career chasing the notorious RAS oncogene that earned him the inaugural Stephenson...